Cramer's Take on Headline Stocks
Stockpickr Staff
06/29/09 - 05:20 PM EDT
(Updated with stock prices.)Bernard Madoff, perpetrator of the multibillion-dollar Ponzi scheme that destroyed the financial health of hundreds, even thousands, of people, received a
150-year jail sentence on Monday morning.
Also making headlines,
Microsoft(MSFT) might unload a 2007 acquisition, Razorfish, to a French marketing company. Microsoft closed up 51 cents, or $2.18, at $23.86 on Monday.
Swiss drug company
Novartis(NVS) is reportedly considering a purchase of
Elan's(ELN) multiple sclerosis treatment, Tsyabri, and other operations from the Irish biotech. Novartis closed down 17 cents at $41.17 on Monday, while Elan slid 41 cents, or 5.6%, to $6.95
And in
analyst upgrade-downgrade news, Deutsche Bank downgraded
Biogen Idec(BIIB) to hold from buy, Friedman Billings Ramsey downgraded
Alcoa(AA) to underperform, and Credit Suisse upgraded
KB Home(KBH) to neutral from underperform.
Biogen lost $2.75, or 5.5%, on Monday to close at $47.32; Alcoa slid 32 cents, or 3%, to $10.44; and KB Home added 69 cents, or 5.1%, to $14.11.
With this in mind, we thought we'd take a look at some of the stocks in the news and see what Jim Cramer's had to say about them lately.
To read more,
visit Stockpickr.com.